Delivery Order SPE2DB22D1106-SPE2DB24FEYP8

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award, valued at $19,205.87, is for the delivery of 4,564,881,167 units of Concerta ER 36 mg tablets. The contract is a firm fixed-price delivery order with a completion date of June 12, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,597,355 units of Concerta ER 27 mg tablets. The $6,215.99 firm fixed-price delivery order has a completion date of December 4, 2024 and was awarded on December 3, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,566,135,512 units of Concerta ER 18 mg tablets. The $3,906.67 firm fixed-price contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,881,478 Concerta ER 27 mg tablets over a 2-year period ending on June 6, 2024. The $13,520.41 firm-fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Concerta ER 54 mg tablets. The $12,691.60 firm fixed-price delivery order has an ultimate completion date of January 9, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,563,143,484 tablets of Concerta ER 27 mg. The $21,860.35 fixed-price delivery order has an ultimate completion date of December 20, 2023. This contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a delivery order for 4,566,503,764 units of Concerta ER 36 mg tablets. The $7,193.09 firm fixed-price award was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $1,244.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,842,897 units of Concerta ER 18 mg tablets, a neurological medication. The contract has a firm fixed price and an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Concerta ER 27 mg tablets. The contract, valued at $3,647.44, is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Concerta ER 27 mg tablets. The $6,768.07 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies and equipment to military treatment facilities. The contract has a completion date of September 16, 2024 and is not set aside for any specific business type. Amerisourcebergen holds...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEYP8
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) for the delivery of 4,564,997,894 units of Concerta ER 27 mg tablets. The contract, valued at $3,726.01, is a firm fixed-price delivery order with a completion date of June 26, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/24/24, 9:36 AM